
CAMRF
Healthcare · Biotechnology · $4.28B market cap
$71.900.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | After the close | 4.36 | — | — |
| Feb 13, 2023 | After the close | 0.29 | 0.23 | -20.7% |
| Nov 9, 2022 | After the close | 0.14 | 0.63 | +350.0% |
| Jul 14, 2022 | After the close | -0.24 | 0.14 | +158.3% |
| May 11, 2022 | After the close | -0.26 | -0.01 | +96.2% |
| Feb 15, 2022 | After the close | -0.32 | -0.26 | +18.8% |
| Nov 3, 2021 | After the close | — | -0.11 | — |
| Jul 14, 2021 | After the close | -0.52 | -0.89 | -71.2% |
| May 6, 2021 | Before the open | -0.97 | -0.40 | +58.8% |
| Feb 10, 2021 | After the close | — | -1.22 | — |
| Nov 4, 2020 | After the close | 0.00 | -0.38 | — |
| Jul 15, 2020 | After the close | 0.00 | -0.04 | — |
| May 7, 2020 | Before the open | 0.00 | -0.04 | — |
Camurus AB (publ), a biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia. The company offers Buvidal, a buprenorphine injection for the treatment of opioid dependence and chronic pain; and Brixadi to treat opioid use disorder. It also provides CAM2038 for the treatment of chronic pain; CAM2029, which completed…
| Feb 11, 2020 | After the close | — | -1.47 | — |
| Nov 7, 2019 | After the close | — | -1.31 | — |
| Jul 17, 2019 | After the close | -1.93 | -1.83 | +5.2% |
| May 9, 2019 | Before the open | -1.74 | -1.50 | +13.8% |
| Feb 5, 2019 | After the close | -3.02 | -2.08 | +31.1% |
| Oct 24, 2018 | After the close | -1.56 | -1.04 | +33.3% |
| Jul 16, 2018 | After the close | -1.01 | -1.66 | -64.4% |
| May 3, 2018 | Before the open | -1.10 | -0.89 | +19.1% |
| Feb 14, 2018 | After the close | -2.01 | -1.28 | +36.3% |